dopamine hci

Generic: dopamine hci

Labeler: hf acquisition co. llc, dba health first
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name dopamine hci
Generic Name dopamine hci
Labeler hf acquisition co. llc, dba health first
Dosage Form INJECTION, SOLUTION, CONCENTRATE
Routes
INTRAVENOUS
Active Ingredients

dopamine hydrochloride 40 mg/mL

Manufacturer
HF Acquisition Co. LLC, DBA Health First

Identifiers & Regulatory

Product NDC 51662-1220
Product ID 51662-1220_11ffcdfd-1b2f-90a1-e063-6394a90adede
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA018132
Listing Expiration 2026-12-31
Marketing Start 2018-08-23

Pharmacologic Class

Classes
catecholamine [epc] catecholamines [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 516621220
Hyphenated Format 51662-1220

Supplemental Identifiers

RxCUI
1743938
UNII
7L3E358N9L

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name dopamine hci (source: ndc)
Generic Name dopamine hci (source: ndc)
Application Number NDA018132 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 40 mg/mL
source: ndc
Packaging
  • 10 mL in 1 VIAL, SINGLE-DOSE (51662-1220-1)
  • 25 POUCH in 1 CASE (51662-1220-3) / 1 VIAL, SINGLE-DOSE in 1 POUCH (51662-1220-2) / 10 mL in 1 VIAL, SINGLE-DOSE
source: ndc

Packages (2)

Ingredients (1)

dopamine hydrochloride (40 mg/mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "11ffcdfd-1b2f-90a1-e063-6394a90adede", "openfda": {"unii": ["7L3E358N9L"], "rxcui": ["1743938"], "spl_set_id": ["74205252-3949-57fa-e053-2991aa0aee4d"], "manufacturer_name": ["HF Acquisition Co. LLC, DBA Health First"]}, "finished": true, "packaging": [{"sample": false, "description": "10 mL in 1 VIAL, SINGLE-DOSE (51662-1220-1)", "package_ndc": "51662-1220-1", "marketing_start_date": "20180823"}, {"sample": false, "description": "25 POUCH in 1 CASE (51662-1220-3)  / 1 VIAL, SINGLE-DOSE in 1 POUCH (51662-1220-2)  / 10 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "51662-1220-3", "marketing_start_date": "20221110"}], "brand_name": "DOPAMINE HCI", "product_id": "51662-1220_11ffcdfd-1b2f-90a1-e063-6394a90adede", "dosage_form": "INJECTION, SOLUTION, CONCENTRATE", "pharm_class": ["Catecholamine [EPC]", "Catecholamines [CS]"], "product_ndc": "51662-1220", "generic_name": "DOPAMINE HCI", "labeler_name": "HF Acquisition Co. LLC, DBA Health First", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "DOPAMINE HCI", "active_ingredients": [{"name": "DOPAMINE HYDROCHLORIDE", "strength": "40 mg/mL"}], "application_number": "NDA018132", "marketing_category": "NDA", "marketing_start_date": "20180823", "listing_expiration_date": "20261231"}